Fusion Antibodies PLC
LSE:FAB
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is FAB's stock price target?
Not Available
FAB doesn't have any price targets made by Wall Street professionals.
What is Fusion Antibodies PLC's Revenue forecast?
Projected CAGR
-43%
For the last 7 years the compound annual growth rate for Fusion Antibodies PLC's revenue is 10%. The projected CAGR for the next 1 year is -43%.